Marshall & Sullivan Inc. WA boosted its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 6.5% during the first quarter, Holdings Channel reports. The institutional investor owned 39,324 shares of the company’s stock after buying an additional 2,404 shares during the period. Express Scripts Holding makes up about 2.1% of Marshall & Sullivan Inc. WA’s investment portfolio, making the stock its 22nd largest position. Marshall & Sullivan Inc. WA’s holdings in Express Scripts Holding were worth $2,372,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Caxton Associates LP purchased a new position in shares of Express Scripts Holding during the first quarter valued at about $468,000. Tudor Investment Corp ET AL boosted its position in shares of Express Scripts Holding by 274.3% in the first quarter. Tudor Investment Corp ET AL now owns 234,995 shares of the company’s stock valued at $15,489,000 after buying an additional 172,209 shares in the last quarter. Cambria Investment Management L.P. boosted its position in shares of Express Scripts Holding by 1.2% in the first quarter. Cambria Investment Management L.P. now owns 17,176 shares of the company’s stock valued at $1,132,000 after buying an additional 209 shares in the last quarter. Westwood Holdings Group Inc. boosted its position in shares of Express Scripts Holding by 15.6% in the first quarter. Westwood Holdings Group Inc. now owns 69,700 shares of the company’s stock valued at $4,594,000 after buying an additional 9,400 shares in the last quarter. Finally, Endurant Capital Management LP boosted its position in shares of Express Scripts Holding by 22.8% in the first quarter. Endurant Capital Management LP now owns 118,027 shares of the company’s stock valued at $7,779,000 after buying an additional 21,900 shares in the last quarter. 90.20% of the stock is currently owned by institutional investors.

Express Scripts Holding Company (NASDAQ:ESRX) traded down 1.14% on Thursday, reaching $60.50. 1,198,549 shares of the company’s stock were exchanged. The stock has a market capitalization of $34.94 billion, a P/E ratio of 10.50 and a beta of 0.90. The firm’s 50 day moving average is $62.96 and its 200 day moving average is $64.58. Express Scripts Holding Company has a 1-year low of $57.80 and a 1-year high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. During the same quarter last year, the company posted $1.57 EPS. Express Scripts Holding’s revenue for the quarter was up .5% on a year-over-year basis. Analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/10/marshall-sullivan-inc-wa-purchases-2404-shares-of-express-scripts-holding-company-nasdaqesrx.html.

Several equities analysts have issued reports on the stock. BidaskClub cut shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research note on Friday, August 4th. Needham & Company LLC assumed coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating on the stock. Cowen and Company reissued an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. ValuEngine cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Evercore ISI dropped their price objective on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th. Four equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Express Scripts Holding currently has a consensus rating of “Hold” and a consensus target price of $70.81.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.